PH12920A - Composition and method for treatment of hepatic diseases and mental fatigue - Google Patents

Composition and method for treatment of hepatic diseases and mental fatigue

Info

Publication number
PH12920A
PH12920A PH12897A PH12897A PH12920A PH 12920 A PH12920 A PH 12920A PH 12897 A PH12897 A PH 12897A PH 12897 A PH12897 A PH 12897A PH 12920 A PH12920 A PH 12920A
Authority
PH
Philippines
Prior art keywords
treatment
composition
mental fatigue
hepatic diseases
hepatic
Prior art date
Application number
PH12897A
Inventor
P Causa
G Perri
Original Assignee
Richardson Merrell Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Spa filed Critical Richardson Merrell Spa
Publication of PH12920A publication Critical patent/PH12920A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH12897A 1970-10-15 1971-10-05 Composition and method for treatment of hepatic diseases and mental fatigue PH12920A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8093670A 1970-10-15 1970-10-15

Publications (1)

Publication Number Publication Date
PH12920A true PH12920A (en) 1979-10-10

Family

ID=22160611

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12897A PH12920A (en) 1970-10-15 1971-10-05 Composition and method for treatment of hepatic diseases and mental fatigue

Country Status (9)

Country Link
AU (1) AU3460571A (en)
BE (1) BE773910A (en)
DE (1) DE2150900A1 (en)
FR (1) FR2110465A1 (en)
GB (1) GB1310658A (en)
IL (1) IL37904A0 (en)
NL (1) NL7114199A (en)
PH (1) PH12920A (en)
ZA (1) ZA716628B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0059775B1 (en) * 1980-06-09 1984-09-19 Leopold & Co. Chem. pharm. Fabrik Gesellschaft m.b.H. Infusion solution for the protection of the liver and the improvement of its functioning, and process for its production
GB2199243A (en) * 1986-09-17 1988-07-06 Natural Vitality Ltd Pharmaceutical compositions comprising ornithine and arginine
ES2038733T3 (en) * 1987-12-04 1993-08-01 Asta Medica Ag PROCEDURE FOR PREPARING AN INJECTABLE SOLUTION OF THIOCTIC ACID SALT WITH THROMETHANOL AND / OR BASIC AMINO ACIDS.
FR2653997B1 (en) * 1989-11-09 1995-01-20 Asta Pharma Ag MEDICINAL PRODUCTS CONTAINING SULSTERS OF SULFUR CARBOXYLIC ACIDS, THEIR PREPARATION AND THEIR USE FOR CONTROLLING RETROVIRUSES.
FR2791571B1 (en) * 1999-04-02 2002-10-04 Sod Conseils Rech Applic ASSOCIATION OF NO SYNTHASE INHIBITOR (S) AND METABOLIC ANTIOXIDANT (S)
US9486429B2 (en) 1999-06-01 2016-11-08 Vanderbilt University Therapeutic methods employing nitric oxide precursors
US6346382B1 (en) * 1999-06-01 2002-02-12 Vanderbilt University Human carbamyl phosphate synthetase I polymorphism and diagnostic methods related thereto
MXPA02007466A (en) * 2000-02-01 2004-02-26 Muscletech Res And Dev Inc agr; LIPOIC ACID BASED FOOD SUPPLEMENT FOR INCREASING LEAN MUSCLE MASS AND STRENGTH.
JP3907964B2 (en) * 2001-04-25 2007-04-18 株式会社 伊藤園 Mental fatigue reducing composition, concentration maintenance enhancing composition and mental vitality maintenance enhancing composition
KR20050009718A (en) * 2002-05-29 2005-01-25 유니레버 엔.브이. Odor control in amine salt containing cosmetic composition
PT2319581E (en) 2004-11-26 2015-06-30 Ucl Business Plc COMPOSITIONS UNDER ORNITINE AND PHENYL ACETATE OR PHENYLBUTIRATE FOR TREATMENT OF HEPATIC ENCEPHALOPATHY
WO2007040244A1 (en) * 2005-10-04 2007-04-12 Kyowa Hakko Kogyo Co., Ltd. Composition for relieving subjective symptoms of fatigue
EP2050444B1 (en) * 2006-06-07 2011-05-11 Kyowa Hakko Bio Co., Ltd. Fatigue-reducing agent
US8945655B2 (en) 2007-07-10 2015-02-03 Conopco, Inc. Stable and consumable compositions
PL2240170T3 (en) 2008-01-31 2019-11-29 Univ Vanderbilt Methods and compositions for treatment for coronary and arterial aneurysmal subarachnoid hemorrhage
CN106810464B (en) 2009-04-03 2019-01-22 欧塞拉治疗有限公司 L-ornithine phenylacetate and preparation method thereof
ES2517340T3 (en) 2009-06-08 2014-11-03 Ucl Business Plc Treatment of portal hypertension using L-ornithine and phenylacetate
EP2625162B1 (en) 2010-10-06 2019-03-13 Ocera Therapeutics, Inc. Methods of making l-ornithine phenyl acetate
KR20230018526A (en) 2014-11-24 2023-02-07 유씨엘 비즈니스 리미티드 Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
JP6990170B2 (en) 2015-08-18 2022-01-12 オセラ セラピューティクス, インコーポレイテッド Treatment and prevention of muscle loss using L-ornithine in combination with at least one of phenylacetate and phenylbutyrate
MX389665B (en) 2017-05-11 2025-03-20 Ocera Therapeutics Inc PROCESSES FOR PRODUCING L-ORNITHINE PHENYLACETATE

Also Published As

Publication number Publication date
IL37904A0 (en) 1971-12-29
GB1310658A (en) 1973-03-21
ZA716628B (en) 1972-06-28
FR2110465A1 (en) 1972-06-02
BE773910A (en) 1972-01-31
NL7114199A (en) 1972-04-18
AU3460571A (en) 1973-04-19
DE2150900A1 (en) 1972-04-20

Similar Documents

Publication Publication Date Title
IL37904A0 (en) Composition and method for treatment of hepatic diseases and mental fatigue
ZA718284B (en) Method and apparatus for the continuous treatment of fibrous materials
PH10336A (en) Nono-chromone-2-carboxylic acid and method and composition for the treatment of asthma
IL36021A (en) Process and apparatus for the continuous treatment of threads
ZA728567B (en) Method and compositions for the treatment of human hair
AU458749B2 (en) Process for the treatment and care of dentures
CS190371B2 (en) Means for destroying the phytopatogenous organism and method of making the active agents
AU464700B2 (en) Composition and method of treatment
ZA713249B (en) Therapeutic process and compositions
AU462834B2 (en) Pharmaceutical composition and method of treatment
ZA713073B (en) Anthelmintic composition and method of use
BE765352A (en) METHOD AND COMPOSITION FOR THE TREATMENT OF
IL37953A0 (en) Substituted oxazepines and method of use
PH12038A (en) Composition containing cyclobenzaprine for use in the treatment of skeletal muscle disorders and method of treatmen
BE774917A (en) COMPOSITION FOR THE TREATMENT OF THE HAIR AND METHOD FOR PREPARING THIS COMPOSITION
CH537160A (en) Equipment for fermentation and / or heat treatment of tobacco
IL37923A0 (en) Process for the treatment of dentures with silicon oil
IE35467B1 (en) Treatment of fats and oils
AU462687B2 (en) Hydrotherapy tank uner and method of giving hydrotherapy treatment
CA837050A (en) Method of and composition for the treatment of human carcinoma and hypercholestrolemia
ZA708706B (en) Antheilmintic composition and method of use
ZA711821B (en) Pharmaceutical compositions and methods of treatment
ZA71461B (en) Method of treating parkinson's disease
ZA714297B (en) Process for the treatment of woollen material and blends thereof
ZM2771A1 (en) Treatment of anaplasmosis in cattle